Medicinal plants are a common denominator for care and therapy across different time periods and civilizations, ranging from Indian Ayurveda, classic Greek and medieval Arabian to modern European medicine.
By leveraging traditional knowledge, the Alpinia Institute of Phytopharmaceutical Sciences uses modern research methods and technologies to develop medical and health care products.
Since the establishment of the Alpinia Institute in 2008, the company has been pursuing the scientific development of medicines based on plants with high therapeutic potential. Extracts are clinically tested in collaboration with renowned research institutes and hospitals.
The institute is equipped with state-of-the-art research and development laboratories, along with an auditorium for scientific congresses, seminars and symposia events.
Frankincense: General use as a medicine
Frankincense is the naturally occurring resin of frankincense trees which belong to the botanical genus Boswellia and which are native to the hot and arid climate zones of eastern Africa, southern Arabia and the Indian subcontinent. The precious resin is collected by peeling the outer layer of the bark of a frankincense tree. After a few days the resin exuded at the treated zone is collected from the trunk and dried, cleaned and graded. Frankincense consists of a mixture of essential oil, mucilage polysaccharides and resinous acids and is defined as oleo gum resin.
Since the 1980s, frankincense has increasingly attracted scientific attention as an agent of potentially high medicinal value. To date, numerous pharmacological and clinical studies have been conducted, especially with Indian frankincense from Boswellia serrata which is now listed in the European Pharmacopoeia.
Meanwhile, an extensive body of laboratory data is available for frankincense, based on which a broad activity profile has been deduced including anti-inflammatory effects. Clinical data demonstrate the efficacy of frankincense extracts, in comparison to placebo or reference drugs, in arthritic conditions, chronic inflammatory diseases of the intestines, and bronchial asthma.
Frankincense and its extracts also reveal an exceedingly favourable preclinical and clinical safety profile and, in comparison to orally applied standard anti-inflammatory drugs, are less prone to cause adverse effects. Today, frankincense is being re-discovered also as a therapeutic for dermal application in various inflammatory skin conditions and different research groups currently explore the resin’s potential in this context.
Alpinia produces a special frankincense resin extract manufactured by using the highest – pharmaceutical – quality of resin obtained from the Indian frankincense tree Boswellia serrata and which preserves the valuable properties of frankincense.